Medicines

Simulect 20 mg powder and solvent for solution for infusion or injection

BASILIXIMAB

Strength
20mg
Form
Powder for Solution for Injection/Infusion
Manufacturer
NOVARTIS PHARMA S.A.S. · France
Rwanda FDA registration
RWANDA-FDA25/HM/0261/0039
Product information

BASILIXIMAB

Product type
human medicine
Regulatory status
valid